Rein Therapeutics, Inc. (RNTX) › Shares OutstandingRein Therapeutics, Inc. (RNTX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2016: 432.4K2017: 14.72M2018: 14.75M2019: 27.81M2020: 43.80M2021: 4.53M2022: 4.54M2023: 4.89M2024: 21.67M2025: 27.55M27.55M2016Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202527.55M+27.2%202421.67M+343.5%20234.89M+7.6%20224.54M+0.3%20214.53M-89.7%202043.80M+57.5%201927.81M+88.6%201814.75M+0.2%201714.72M+3305.0%2016432.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share